1144225--5/18/2009--instaCare

related topics

{stock, price, share}

{system, service, information}

{condition, economic, financial}

{capital, credit, financial}

{product, liability, claim}

{control, financial, internal}

{property, intellectual, protect}

{interest, director, officer}

{acquisition, growth, future}

{product, market, service}

Declining economic conditions could negatively impact our business Continued instability of the U.S. financial system may have a negative impact on our business. We have historically lost money and losses are expected to continue in the near future, which means that we may not be able to continue operations unless we obtain additional funding. We have been dependent on a small number of major customers to support our prescription drug distribution plan and to refer direct to patient business. Our internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public. We may not be able to retain our key personnel or attract additional personnel, which could affect our ability to generate revenue sufficient to continue as a going concern diminishing your return on investment. Achieving market acceptance of new or newly integrated products and services is likely to require significant efforts and expenditures. We could be subject to breach of warranty claims if our software products, information technology systems or transmission systems contain errors, experience failures or do not meet customer expectations. If our systems or the Internet experience security breaches or are otherwise perceived to be insecure, we could lose existing clients and limit our ability to attract new clients. We do not have the financial resources to litigate actions involving our copyrights or patent applications. Our auditors have expressed substantial doubt as to our ability to continue as a going concern. If we fail to remain current on our reporting requirements, we could be removed from the OTC Bulletin Board, which would limit the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market. Because our common stock is deemed a low-priced Penny stock, an investment in our common stock should be considered high risk and subject to marketability restrictions. Recent and possible future issuances of common stock will have a dilutive effect on existing shareholders. Our common stock has been relatively thinly traded, may experience high price volatility and we cannot predict the extent to which a trading market will develop. FINRA sales practice requirements may also limit a stockholder's ability to buy and sell our stock.

Full 10-K form ▸

1144225--5/18/2009--instaCare_Corp.